These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 38984187)
1. Elevated Procalcitonin Levels can Occur in Bacterial Infections and also in Medullary Thyroid Carcinoma. Kaya F; Alsafdi T Eur J Case Rep Intern Med; 2024; 11(7):004679. PubMed ID: 38984187 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen. Woliński K; Kaznowski J; Klimowicz A; Maciejewski A; Łapińska-Cwojdzińska D; Gurgul E; Car AD; Fichna M; Gut P; Gryczyńska M; Ruchała M Endokrynol Pol; 2017; 68(4):434-437. PubMed ID: 28585679 [TBL] [Abstract][Full Text] [Related]
3. Clinical performance of calcitonin and procalcitonin Elecsys Giovanella L; Fontana M; Keller F; Verburg FA; Ceriani L Clin Chem Lab Med; 2021 Mar; 59(4):743-747. PubMed ID: 33085633 [TBL] [Abstract][Full Text] [Related]
4. Serum Biochemical Markers for Medullary Thyroid Carcinoma: An Update. Liu S; Zhao H; Li X Cancer Manag Res; 2024; 16():299-310. PubMed ID: 38617188 [TBL] [Abstract][Full Text] [Related]
5. A Review of the Significance in Measuring Preoperative and Postoperative Carcinoembryonic Antigen (CEA) Values in Patients with Medullary Thyroid Carcinoma (MTC). Passos I; Stefanidou E; Meditskou-Eythymiadou S; Mironidou-Tzouveleki M; Manaki V; Magra V; Laskou S; Mantalovas S; Pantea S; Kesisoglou I; Sapalidis K Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34208296 [No Abstract] [Full Text] [Related]
6. Incidental diagnosis of medullary thyroid carcinoma due to persistently elevated procalcitonin in a patient with COVID-19 pneumonia: A case report. Saha A; Mukhopadhyay M; Paul S; Bera A; Bandyopadhyay T World J Clin Cases; 2022 Jul; 10(20):7171-7177. PubMed ID: 36051107 [TBL] [Abstract][Full Text] [Related]
7. Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors? Behr TM; Gratz S; Markus PM; Dunn RM; Hüfner M; Schauer A; Fischer M; Munz DL; Becker H; Becker W Cancer; 1997 Dec; 80(12 Suppl):2436-57. PubMed ID: 9406695 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic Performance of Preoperative Calcitonin and Procalcitonin Tests for Differential Diagnosis of Medullary Thyroid Cancer. Jeong IY; Yun HJ; Kim SM; Park Y Diagnostics (Basel); 2024 Aug; 14(16):. PubMed ID: 39202297 [TBL] [Abstract][Full Text] [Related]
10. Calcitonin and complementary biomarkers in the diagnosis of hereditary medullary thyroid carcinoma in children and adolescents. Eckelt F; Pfaeffle R; Kiess W; Kratzsch J J Pediatr Endocrinol Metab; 2021 Dec; 34(12):1491-1504. PubMed ID: 34543539 [TBL] [Abstract][Full Text] [Related]
11. Case report of a neuroendocrine tumor of the thyroid gland with limited calcitonin expression: a diagnostic challenge. Sukpanich R; Khanafshar E; Suh I; Gosnell J AME Case Rep; 2019; 3():12. PubMed ID: 31231713 [TBL] [Abstract][Full Text] [Related]
12. Calcitonin and procalcitonin in patients with medullary thyroid cancer or bacterial infection. Kaczka K; Mikosiński S; Fendler W; Celnik A; Pomorski L Adv Clin Exp Med; 2012; 21(2):169-78. PubMed ID: 23214280 [TBL] [Abstract][Full Text] [Related]
13. Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma. Ye L; Zhou X; Lu J; Wang Y; Xie X; Zhang J J Clin Lab Anal; 2020 Jul; 34(7):e23278. PubMed ID: 32141647 [TBL] [Abstract][Full Text] [Related]
14. Other markers of medullary thyroid cancer, not only calcitonin. Censi S; Manso J; Mian C Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36651167 [TBL] [Abstract][Full Text] [Related]
15. Medullary Thyroid Carcinoma With Elevated Serum CEA and Normal Serum Calcitonin After Surgery: A Case Report and Literature Review. Chen L; Zhao K; Li F; He X Front Oncol; 2020; 10():526716. PubMed ID: 33194586 [TBL] [Abstract][Full Text] [Related]
16. T Cells Engineered to Express Immunoreceptors Targeting the Frequently Expressed Medullary Thyroid Cancer Antigens Calcitonin, CEA, and RET M918T. Erickson TA; Shih YP; Fass J; Jang M; Tran E Thyroid; 2022 Jul; 32(7):789-798. PubMed ID: 35587601 [No Abstract] [Full Text] [Related]
17. Uncovering the Uncommon: An 81-Year-Old Woman With Elevated Carcinoembryonic Antigen (CEA) but Normal Calcitonin Levels Diagnosed With Medullary Thyroid Carcinoma. Ukrani J; Barnes M; Ashraf A; Haggerty G; Dacosta N Cureus; 2023 Jun; 15(6):e40290. PubMed ID: 37448402 [TBL] [Abstract][Full Text] [Related]
18. Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma. Algeciras-Schimnich A; Preissner CM; Theobald JP; Finseth MS; Grebe SK J Clin Endocrinol Metab; 2009 Mar; 94(3):861-8. PubMed ID: 19088163 [TBL] [Abstract][Full Text] [Related]
19. Procalcitonin: A New Biomarker for Medullary Thyroid Cancer? A Systematic Review. Karagiannis AK; Girio-Fragkoulakis C; Nakouti T Anticancer Res; 2016 Aug; 36(8):3803-10. PubMed ID: 27466480 [TBL] [Abstract][Full Text] [Related]
20. Persistence of Elevated Procalcitonin in a Patient with Coronavirus Disease 2019 Uncovered a Diagnosis of Medullary Thyroid Carcinoma. Gianotti L; D'Agnano S; Pettiti G; Tassone F; Giraudo G; Lauro C; Lauria G; Del Bono V; Borretta G AACE Clin Case Rep; 2021; 7(5):288-292. PubMed ID: 33997278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]